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Vorwort 
 
Die vorliegende Habilitationsschrift umfasst Arbeiten, die im Verlauf meiner 
klinischen Forschungstätigkeit auf dem Gebiet der venösen Thrombose 
enstanden sind. 
 
Die nachfolgend aufgeführten Originalartikel, ergänzt durch ein Editorial, 
werden als Habilitationsschrift eingereicht. Für das Verständnis des Themas 
wichtige Daten der Literatur werden im Sinne einer Synthese beigefügt und im 
Zusammenhang mit den eigenen Ergebnissen kommentiert. 
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Introduction 
 
Virchow’s triad which summarizes the pathogenetic mechanism of (venous) 
thrombosis includes alterations in blood flow (stasis), injury to the vascular 
endothelium, and alterations in the constitution of blood. The research of the 
past 150 years resulted in the description of the mechanisms of plasmatic 
coagulation, while, in the second half of last century, defects in the 
constitution of blood were identified as the cause of thrombophilia [1]. The 
mechanism by which blood stasis as one of the pathogenetic mechanisms 
can lead to the development of deep vein thrombosis even in healthy 
subjects, however, is incompletely understood. One situation associated with 
blood stasis in the lower limbs is a prolonged immoblisation in a sitting 
position, as is frequently encountered during a long (air) trip. The issues in the 
context of travel-induced thrombosis motivated the studies which will be 
presented hereafter. 
 
Does venous stasis induce activation of coagulation? 
 
When hemostasis is required, e.g. following a lesion in the vessel wall, 
thrombin is generated in a biphasic mode: During an initiation phase, 
picomolar amounts of the enzyme are formed due to the action of the complex 
TF-FVIIa on factor X. In the subsequent propagation phase, the majority of 
thrombin is formed due to the action of the intrinsic system [2]. To prevent 
excess thrombin generation, there are three partially interdependent major 
natural anticoagulant mechanisms which eventually result in a reduced 
thrombin formation or in an increased thrombin neutralization in vivo: the 
tissue factor inhibitory pathway which regulates the initiation phase, the 
heparin-antithrombin system, and the protein C pathway, which both control 
the propagation phase [3,4]. Also, in a so-called prethrombotic state which 
biochemically is defined by an increased level of prothrombin fragment 1+2 
(F1+2, a marker of thrombin generation) but a normal level of fibrinopeptide A 
(FPA, a marker of fibrin formation) the coagulation is contained by natural 
inhibitors of thrombin [5]. Interestingly, low-grade thrombin generation has 
been shown to occur in healthy individuals both due to a minimal activation of 
the extrinsic coagulation pathway [6] or in a tissue-factor independent manner 
[7]. In healthy individuals, however, the coagulation activation is maintained in 
a finely tuned equilibrium by the plasmatic inhibitors cited above.  
If venous stasis is a risk factor for thrombosis, a prethrombotic state would be 
present and detectable by measuring the concentrations of the specific 
markers in a situation of compromised blood flow. In an experimental model, 
we imitated the situation during travel by immobilising healthy volunteers kept 
seated on a chair for 6 hours. At baseline, and after 3 and 6 hours, venous 
blood was drawn from the forearm in a manner as not to induce activation of 
coagulation. In 40 volunteers, we found no increase (which excludes 
coagulation activation) but a decrease in the concentration of F1+2 
(p=0.0001), which is in line with a decreased thrombin generation during 
sitting. The decrease in F1+2 plasma level was both relevant in quantitative 
terms (-20% of the baseline value) and consistent across the volunteers 
(being present in 80% of them). FPA and D-dimer, the molecular markers of 
ongoing fibrin deposition and lysis, did not increase. These unexpected 
results contrasted with our original hypothesis and generated further 
questions: can the decrease in F1+2 concentrations be explained with 
circadian variations, or is it the consequence of venous stasis? 
 
Issue of decreased thrombin generation while sitting 
 
In order to disentangle the influence of a possible circadian variation from the 
effect of immobilisation we also examined a subgroup of the original 
volunteers during daily activity. Whereas during sitting the concentration of 
F1+2 decreased, we did not observe a change of this marker while the 
subjects were ambulant. In a second study, we applied tourniquets around the 
thighs of 10 volunteers and measured coagulation markers such as F1+2 at 
baseline and after 30 minutes in a blood sample drawn from a brachial vein. 
Again we found a significant decrease in F1+2 (p=0.03). Both findings 
resulting from two different models of immobilisation led to the conclusion that 
the decrease in thrombin generation was due to stasis and not to circadian 
variation. In the light of these results, the question remains if a decrease of 
thrombin generation is protective or at the contrary a hazard for 
thromboembolism. 
 
Possible mechanisms which link a decreased thrombin generation to a 
prethrombotic state: the protein C system 
 
Thrombin has a dual function: as a procoagulant it is the key effector enzyme 
of the coagulation system, and as an anticoagulant it stimulates the 
expression of thrombomodulin and, by its binding to the latter, enhances 
protein C activation [1]. 
In a similar experimental model of subjects immobilised for 6 hours in a sitting 
position we assessed the protein C system by measuring the concentration of 
thrombomodulin and the activities of coagulation factor Va and VIIIa. At the 
end of the study, thrombomodulin decreased by 16% (p=0.0001), and the 
activities of both coagulation factors increased significantly (p=0.04 and 
0.0004, respectively). These findings are consistent with an enhanced risk for 
coagulation activation: less thrombomodulin as well as higher activities of 
factor VIIIa were shown to correlate with a higher incidence of venous 
thrombosis [8, 9].  
Venous thromboembolism after air travel was first recorded in 1954, but a 
relation between travel and thrombosis has been questioned until recently 
[10]. In a landmark study, however, the incidence of thromboembolism was 
shown to be related to air travel and depended on the flight duration [11]. An 
increase in the risk of thromboembolism in passengers undertaking long-haul 
flights may be caused by long term immobilisation in a cramped position, the 
cabin environment of hypobaric hypoxia, or dehydration, acting synergistically 
with personal risk factors. There has been inconsistent findings as to these 
mechanism that may induce coagulation activation during travelling. In a 
recent controlled study, hypobaric hypoxia did not result in coagulation 
activation, but the low number of included subjects could not exclude such an 
activation in more susceptible individuals [12]. 
Two recent studies addressing the issue of hypobaric hypoxia, both 
conducted within the framework of the WHO Research into the Global 
Hazards of Travel, provided contrasting results. The first study included 
participants with no genetic thrombophilic risk factors. Individuals were 
exposed alternatively to hypobaric hypoxia (in a hypobaric chamber) and to 
normobaric normoxia. There was no diffference in parameters of coagulation, 
fibrinolysis, platelet function, and endothelial activation between the two 
experimental conditions [13]. In the second study it was shown that in 
susceptible subjects immobilised during an 8 hours flight, coagulation markers 
increased, which was not the case when immobilisation occurred for the same 
time period in a cinema, or during daily activities [14]. The conclusion of this 
study that a hypobaric hypoxic environment typically encountered in aircrafts 
is the main pathogenetic factor that explains travel-induced thrombosis, 
however, must be weighed against the fact that thrombosis can also result 
after a trip by bus or by train, a situation where prolonged sitting is not 
associated with hypobaric hypoxia. Our findings that thrombomodulin is 
downregulated by sitting suggest that venous stasis would induce a decrease 
in thrombomodulin expression, which in turn results in less activation of 
protein C and hence in less inactivation of coagulation factors Va and VIIIa. 
Support for this hypothesis comes from the study of Schreijer et al. where the 
subjects who developed the highest coagulation activation were more 
frequently carrier of the factor V Leiden mutation or took oral contraceptives, 
both conditions that negatively interfere with the performance of the protein C 
system [14]. Less thrombin in an intact vascular bed may thus confer a 
hazard, especially when other parameters negatively influence on the protein 
C system, and may be one of the mechanisms that link blood stasis to 
thrombosis. 
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